Explore 3 Stock Ideas & Industry Insights Download Free Report

Healthcare

Picard Medical (NYSE American: PMI) Sets Investor Briefing Ahead of 2026 Annual Meeting

• Picard Medical (NYSE American: PMI) announced a pre-recorded presentation for shareholders ahead of its July 17, 2026, annual meeting.

Vinay Lochav | 06 July 2026

Nasdaq-Listed NeOnc Technologies (NASDAQ: NTHI) Holdings Inc. Undergoes Shift in Executive Leadership

• Dr. Ming-Fu Chiang stepped down from the Board of Directors and Scientific Advisory Board of NeOnc Technologies effective June 27, 2026.

Vinay Lochav | 06 July 2026

Orthofix Medical (NASDAQ: OFIX) Reverses Medicare Reimbursement Shift After FDA Device Reclass

• Orthofix Medical (NASDAQ: OFIX) projects Medicare reimbursement for non-invasive bone growth stimulators will align with rates before recent policy adjustments.

Vinay Lochav | 06 July 2026

Unicycive Therapeutics (NASDAQ: UNCY) Reports Cash Position of $61.4 Million

• The company’s preliminary financial figures for the period were compiled by management and have not undergone independent review.

Vinay Lochav | 06 July 2026

Arcadia Biosciences (NASDAQ: RKDA) Grants Discretionary Bonus Amid Leadership Changes

• The board approved a discretionary cash bonus for the chief executive, with no other named executives receiving similar awards.

Vinay Lochav | 06 July 2026

Avanos Medical (NYSE: AVNS) Files SEC Disclosure Under Exchange Act Requirements

• The filing states compliance with the Securities Exchange Act.

Vinay Lochav | 06 July 2026

BridgeBio Pharma (NASDAQ: BBIO) Secures $933.9 Million via Preferred Stock Investment

• The firm sold 933,900 shares of its preferred stock, priced at $1,000 each.

Vinay Lochav | 06 July 2026

CorMedix (NASDAQ: CRMD) Appoints New Chief Operating and Commercial Officer

• CorMedix Inc. (NASDAQ: CRMD) named Elizabeth Hurlburt Chief Operating and Commercial Officer on June 29, 2026.

Vinay Lochav | 06 July 2026

Ernexa Therapeutics (NASDAQ: ERNA) Updates Investor Presentation Ahead of Key Developments

• The update aims to provide deeper insights into the company's strategic direction and ongoing projects.

Vinay Lochav | 06 July 2026

LENZ Therapeutics (NASDAQ: LENZ) Board Reshuffled as Zach Scheiner Resigns

• The resignation was not due to any disputes regarding company operations or policies.

Vinay Lochav | 06 July 2026
Support

Hi! How can we help you today?

Loading…